Meet Kallyope’s Nancy Thornberry, Fireside Chat Speaker at #BIOCEO19

Biotech startups come in all shapes, sizes and approaches but have one thing in common: the drive to develop technology that will address a high unmet need and improve patients’ lives.  Nancy Thornberry, the current CEO of Kallyope Inc., didn’t always work for startups, but she has spent a career in drug discovery, always looking to uncover the science that will ultimately lead to real treatments. Kallyope was founded in 2014 and is focused on the study and targeting of the gut-